Monoamine oxidase B (MAO-B) inhibition by active principles from Uncaria rhynchophylla

Wen Chi Hou, Rong Dih Lin, Cheng Tang Chen, Mei Hsien Lee

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Attenuation of monoamine oxidase B (MAO-B) activity may provide protection against oxidative neurodegeneration. For this reason, inhibition of MAO-B activity is used as part of the treatment of Parkinson's and Alzheimer's patients. The hook of Uncaria rhynchophylla (Miq.) Jacks. (Rubiaceae) is a traditional Chinese herbal drug that is generally used to treat convulsive disorders. In this study, the fractionation and purification of Uncaria rhynchophylla extracts using a bioguided assay isolated two known compounds, (+)-catechin and (-)-epicatechin. The compounds inhibited MAO-B, as measured by an assay of rat brain MAO-B separated by electrophoresis on a 7.5% native polyacrylamide gel. The IC50 values of (+)-catechin and (-)-epicatechin were 88.6 and 58.9 μM, respectively, and inhibition occurred in a dose-dependent manner, as measured by the fluorescence method. The Lineweaver-Burk plot revealed Ki values for (+)-catechin and (-)-epicatechin of 74 and 21 μM, respectively. This suggests that these two compounds, isolated here for the first time from Uncaria rhynchophylla, might be able to protect against neurodegeneration in vitro, and, therefore, the molecular mechanism deserves further study. This finding may also increase interest in the health benefits of Uncaria rhynchophylla.

Original languageEnglish
Pages (from-to)216-220
Number of pages5
JournalJournal of Ethnopharmacology
Volume100
Issue number1-2
DOIs
Publication statusPublished - Aug 22 2005

Fingerprint

Uncaria
Catechin
Monoamine Oxidase
Chinese Herbal Drugs
Rubiaceae
Insurance Benefits
Inhibitory Concentration 50
Electrophoresis
Fluorescence
Brain

Keywords

  • (+)-Catechin
  • (-)-Epicatechin
  • Monoamine oxidase B
  • Uncaria rhynchophylla

ASJC Scopus subject areas

  • Pharmacology

Cite this

Monoamine oxidase B (MAO-B) inhibition by active principles from Uncaria rhynchophylla. / Hou, Wen Chi; Lin, Rong Dih; Chen, Cheng Tang; Lee, Mei Hsien.

In: Journal of Ethnopharmacology, Vol. 100, No. 1-2, 22.08.2005, p. 216-220.

Research output: Contribution to journalArticle

@article{6ddfbd772a794efb8d5c5ec33ec5690b,
title = "Monoamine oxidase B (MAO-B) inhibition by active principles from Uncaria rhynchophylla",
abstract = "Attenuation of monoamine oxidase B (MAO-B) activity may provide protection against oxidative neurodegeneration. For this reason, inhibition of MAO-B activity is used as part of the treatment of Parkinson's and Alzheimer's patients. The hook of Uncaria rhynchophylla (Miq.) Jacks. (Rubiaceae) is a traditional Chinese herbal drug that is generally used to treat convulsive disorders. In this study, the fractionation and purification of Uncaria rhynchophylla extracts using a bioguided assay isolated two known compounds, (+)-catechin and (-)-epicatechin. The compounds inhibited MAO-B, as measured by an assay of rat brain MAO-B separated by electrophoresis on a 7.5{\%} native polyacrylamide gel. The IC50 values of (+)-catechin and (-)-epicatechin were 88.6 and 58.9 μM, respectively, and inhibition occurred in a dose-dependent manner, as measured by the fluorescence method. The Lineweaver-Burk plot revealed Ki values for (+)-catechin and (-)-epicatechin of 74 and 21 μM, respectively. This suggests that these two compounds, isolated here for the first time from Uncaria rhynchophylla, might be able to protect against neurodegeneration in vitro, and, therefore, the molecular mechanism deserves further study. This finding may also increase interest in the health benefits of Uncaria rhynchophylla.",
keywords = "(+)-Catechin, (-)-Epicatechin, Monoamine oxidase B, Uncaria rhynchophylla",
author = "Hou, {Wen Chi} and Lin, {Rong Dih} and Chen, {Cheng Tang} and Lee, {Mei Hsien}",
year = "2005",
month = "8",
day = "22",
doi = "10.1016/j.jep.2005.03.017",
language = "English",
volume = "100",
pages = "216--220",
journal = "Journal of Ethnopharmacology",
issn = "0378-8741",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Monoamine oxidase B (MAO-B) inhibition by active principles from Uncaria rhynchophylla

AU - Hou, Wen Chi

AU - Lin, Rong Dih

AU - Chen, Cheng Tang

AU - Lee, Mei Hsien

PY - 2005/8/22

Y1 - 2005/8/22

N2 - Attenuation of monoamine oxidase B (MAO-B) activity may provide protection against oxidative neurodegeneration. For this reason, inhibition of MAO-B activity is used as part of the treatment of Parkinson's and Alzheimer's patients. The hook of Uncaria rhynchophylla (Miq.) Jacks. (Rubiaceae) is a traditional Chinese herbal drug that is generally used to treat convulsive disorders. In this study, the fractionation and purification of Uncaria rhynchophylla extracts using a bioguided assay isolated two known compounds, (+)-catechin and (-)-epicatechin. The compounds inhibited MAO-B, as measured by an assay of rat brain MAO-B separated by electrophoresis on a 7.5% native polyacrylamide gel. The IC50 values of (+)-catechin and (-)-epicatechin were 88.6 and 58.9 μM, respectively, and inhibition occurred in a dose-dependent manner, as measured by the fluorescence method. The Lineweaver-Burk plot revealed Ki values for (+)-catechin and (-)-epicatechin of 74 and 21 μM, respectively. This suggests that these two compounds, isolated here for the first time from Uncaria rhynchophylla, might be able to protect against neurodegeneration in vitro, and, therefore, the molecular mechanism deserves further study. This finding may also increase interest in the health benefits of Uncaria rhynchophylla.

AB - Attenuation of monoamine oxidase B (MAO-B) activity may provide protection against oxidative neurodegeneration. For this reason, inhibition of MAO-B activity is used as part of the treatment of Parkinson's and Alzheimer's patients. The hook of Uncaria rhynchophylla (Miq.) Jacks. (Rubiaceae) is a traditional Chinese herbal drug that is generally used to treat convulsive disorders. In this study, the fractionation and purification of Uncaria rhynchophylla extracts using a bioguided assay isolated two known compounds, (+)-catechin and (-)-epicatechin. The compounds inhibited MAO-B, as measured by an assay of rat brain MAO-B separated by electrophoresis on a 7.5% native polyacrylamide gel. The IC50 values of (+)-catechin and (-)-epicatechin were 88.6 and 58.9 μM, respectively, and inhibition occurred in a dose-dependent manner, as measured by the fluorescence method. The Lineweaver-Burk plot revealed Ki values for (+)-catechin and (-)-epicatechin of 74 and 21 μM, respectively. This suggests that these two compounds, isolated here for the first time from Uncaria rhynchophylla, might be able to protect against neurodegeneration in vitro, and, therefore, the molecular mechanism deserves further study. This finding may also increase interest in the health benefits of Uncaria rhynchophylla.

KW - (+)-Catechin

KW - (-)-Epicatechin

KW - Monoamine oxidase B

KW - Uncaria rhynchophylla

UR - http://www.scopus.com/inward/record.url?scp=23044465134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23044465134&partnerID=8YFLogxK

U2 - 10.1016/j.jep.2005.03.017

DO - 10.1016/j.jep.2005.03.017

M3 - Article

VL - 100

SP - 216

EP - 220

JO - Journal of Ethnopharmacology

JF - Journal of Ethnopharmacology

SN - 0378-8741

IS - 1-2

ER -